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Abstract. α-glucosidase is a key enzyme that plays a role 
in glucose absorption in the gastrointestinal tract, and the 
inhibition of its activity induces the prevention of postpran-
dial hyperglycemia. Several α-glucosidase inhibitors have 
been used as medicines for type 2 diabetes, but a similar 
effect is observed in natural resources, including traditional 
herbs and their phytochemicals. To identify the presence 
of the α-glucosidase inhibitory activity in herbs, in which 
various functional effects have been known to occur, the 
present study investigated the effects of hot-water extracts 
of 26 types of herbs on α-glucosidase activity in an in vitro 
assay. The results indicated significant increases in the inhibi-
tion of α-glucosidase activity in 1,000 µg/ml olive (P<0.01), 
white willow (P<0.01) and red rooibos hot-water extracts. 
Furthermore, ≥50% inhibition of α-glucosidase activity was 
determined to be significant in 1,000 µg/ml coltsfoot, green 
tea and bearberry hot-water extracts. in addition, the effects 
of bearberry, green tea and coltsfoot hot-water extracts on 
α-glucosidase activity in vivo were evaluated according 
to the blood glucose levels (BGls) in maltose and glucose 
load model rats. it was indicated that the administration of 
these three herb extracts significantly reduced the increasing 
BGls after maltose loading until 0.5 h compared with the 
control group. However, only coltsfoot extract significantly 
reduced the increasing BGls after glucose loading until 0.5 h 
compared with the control group. Thus, the present results 
may facilitate the understanding of a novel functionality in 
traditional herbs, which could be useful for the prevention of 
disease onset and progression, such as in hyperglycemia and 
type 2 diabetes.
Introduction
Glucose is an essential nutrient in the human body, and its 
uptake via food results in energy production that is used 
by various tissues, having been delivered via the general 
circulation after it is absorbed in the intestine (1). The peak 
of the blood glucose level (BGl) after a meal, as opposed to 
that after fasting, is usually limited to 30-50 mg/dl, and this 
phenomenon is based on the net balance between the rate of 
carbohydrate being absorbed from the gastrointestinal tract 
and the rate at which it is taken up by the liver and peripheral 
tissues (1). Moreover, the disturbance of the net balance results 
in uncontrolled glucose regulation and induces hyperglycemia, 
which is widely recognized as a causal link between diabetes 
and diabetes-related complications (2).
α-glucosidase is a key enzyme that plays a role in glucose 
absorption in the gastrointestinal tract, and inhibition of its 
activity induces the prevention of hyperglycemia (3). in addition, 
α-glucosidase inhibitors such as acarbose, voglibose and 
miglitol have been used as medicines for type 2 diabetes (1,4). 
Furthermore, a similar effect is observed in natural resources. 
For instance, vegetables in the daily diet potentially inhibit 
α-glucosidase activity (5,6). Traditional natural products 
including herbs and their phytochemicals are also known 
for their α-glucosidase-inhibiting activities, and some of 
these products are already sold as functional foods (7,8). our 
previous studies have focused on the biological activity and 
safety of natural products, including food, traditional herbs, 
kampo and their phytochemicals (9-12).
To identify the presence of an α-glucosidase inhibitory 
effect in herbs, in which various functional effects have been 
reported, the present study investigated the effects of hot-water 
extracts of 26 types of herbs on α-glucosidase activity in an 
in vitro assay. in addition, the effects of bearberry, green tea 
and coltsfoot hot-water extracts on α-glucosidase activity 
in vivo were evaluated according to the BGls in maltose- and 
glucose-load model rats.
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Materials and methods
Materials. acarbose, maltose, glycerol and Glucose cii-test 
Wako kit were purchased from Wako Pure chemical industries, 
ltd., unless otherwise stated. all herbs were purchased from 
various companies (Table i). intestinal acetone powders from 
rat were purchased from Sigma-aldrich (Merck KGaa).
Preparation of hot‑water extract from herbs. The extracts 
were prepared from herbs based on a previously described 
method (9). Briefly, 1 g each herb was decocted with 20 ml 
Milli‑Q water at 100˚C for 30 min. After the extracts were 
cooled and filtered, they were used in animal experiments as 
described below. Furthermore, to assess α-glucosidase activity, 
the extracts were evaporated using a freeze dryer, after which 
the dried samples were weighed and dissolved or suspended at 
a concentration of 100 mg/ml in Milli-Q water and stored at 
‑20˚C until further use.
Measurement of α‑glucosidase activity in vitro. α-glucosidase 
activity was measured according to a previously described 
method with modifications (13). Briefly, 10 µl of 72.5 mg/ml 
intestinal acetone powder suspension in 50 mM Tris-Hcl 
(pH 7.8) containing 20% glycerol or Milli‑Q water (blank), 
5 µl of 5.17 µg/ml (8 µM) acarbose (final concentration: 
0.52 µg/ml, as a positive control), 26 types of herb extracts 
(Table i) [concentrations: 2.5, 5.0, 7.5 and 10 mg/ml (final 
concentrations: 250, 500, 750 and 1,000 µg/ml, respectively)] 
and Milli-Q water (control or blank) and 27 µl Milli-Q water 
were mixed in 1.5 ml tubes, and then pre-incubated in a heat 
block at 37˚C for 10 min. Subsequently, 8 µl of 500 mM 
maltose monohydrate solution in Milli‑Q water (final concen-
tration: 80 mM) was added and incubated in a heat block at 
37˚C for 30 min. The tubes were incubated at 100˚C for 2 min 
to terminate the reaction. To assess the amount of glucose 
production, a Glucose cii-test Wako kit was used according to 
the manufacturer's protocol with modifications. Samples were 
centrifuged at 20,400 x g for 5 min, and 2 µl supernatants and 
100 µl chromogenic solution were mixed and incubated in a 
96‑well plate at 37˚C for 5 min. Subsequently, the glucose levels 
of the samples were determined by measuring the absorbance 
at 505 nm using a microtiter plate reader, SpectraMax Pro 
M5e (Molecular devices, llc). The relative α-glucosidase 
inhibitory activity (% of inhibition) was calculated using the 
following equation:
% of inhibition=[(A505 control-a505 blank)-(a505 sample-a505 blank)]/(a505 
control-a505 blank),
where a505 sample denotes the positive control or herb extract 
samples.
The ic50 values were calculated from the relative 
α-glucosidase inhibitory activity curve.
Animals. all experiments and the care and handling of 
animals were approved by the Josai university institutional 
animal care and use committee. in total, 48 male Wistar 
rats (age, 5 weeks; weight, 140-160 g), were obtained from 
clea Japan, inc. The rats were housed in 16 cases, with 
three rats per cage. animals were housed in a 12-h light/dark 
cycle and maintained at a constant temperature of 22±2˚C and 
humidity of 55±10%. The rats were allowed 1 week to adapt 
to the laboratory environment before the experiments and fed 
laboratory pellet chow (ce-2; clea Japan, inc.) and water 
ad libitum. after the experiments had been completed, all rats 
were euthanized via the intraperitoneal injection of sodium 
pentobarbital (150 mg/kg).
To investigate the antihyperglycemic effects based on 
α-glucosidase inhibition in rats, an oral glucose tolerance 
test (oGTT) was performed based on a previously published 
method with modifications (14). The access to pellet chow 
supplied to the rats was denied the night before the experi-
ment. The rats were then randomly divided into five groups: 
Control (n=6); acarbose (24 mg/kg, n=6); bearberry 
(~13.7 mg/ml, n=6); green tea (~8.8 mg/ml, n=6); and coltsfoot 
(~7.2 mg/ml, n=6). All groups were orally administrated with 
distilled water (control), each of three herb extracts or acar-
bose (5 ml/kg, respectively) 0.5 h before oral administration 
of 2 g/kg maltose or glucose. a diagram of the timeline of the 
experiment is presented in Fig. 1.
Measurement of BGLs. Blood samples (~10 µl) were collected 
from all groups into sensor chips (Breeze2 sensor; Panasonic 
corporation) sequentially at 0.083, 0.25, 0.5, 1.0, 1.5, 2.0, 3.0 
and 4.0 h via a small incision in the tail vein using a razor 
blade. Then, the blood samples were measured using a 
glucometer (Breeze2; Bayer Thai co., ltd.). The area under the 
curve (auc) was calculated using GraphPad Prism Ver 8.1.2 
(GraphPad Software, inc.) for subsequent analysis.
Statistical analysis. Statistical analysis was performed with 
GraphPad Prism Ver 8.1.2 (GraphPad Software, inc.) using a 
one-way anoVa (in vitro studies) followed by dunnett's test 
for multiple comparisons and a repeated-measures one-way 
anoVa or a repeated-measures two-way anoVa (in vivo 
studies) followed by Bonferroni's multiple comparison test. 
P<0.05 was considered to indicate a statistically significant 
difference. data from the animal experiments are presented 
as the mean ± SEM or mean ± 95% CI (n=6, respectively), and 
the other data as the mean ± Sd of three separate experiments.
Results
Dose‑dependent inhibitory ef fects of acarbose on 
α‑glucosidase activity. To assess the effects of acarbose on 
α-glucosidase inhibitory activity and to calculate the ic50 
value of acarbose, α-glucosidase activity was assessed in vitro. 
it was demonstrated that α-glucosidase inhibitory activity 
significantly increased in a dose‑dependent manner (Fig. 2A). 
Furthermore, the ic50 value was 0.52 µg/ml (95% CI, 
0.4356-0.6047; r2=0.9528).
Inhibitory effect of herb extracts on α‑glucosidase activity. To 
investigate the α-glucosidase inhibitory effect of the 26 types of 
1,000 µg/ml herb extracts, α-glucosidase activity was assessed 
in vitro (Fig. 2B). Overall, >50% inhibition of α-glucosidase 
activity was significantly demonstrated in 0.52 µg/ml acarbose, 
which served as the positive control, and in 1,000 µg/ml 
coltsfoot, green tea and bearberry extracts. Moreover, significant 
increases in the inhibition of α-glucosidase were observed in 
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1,000 µg/ml olive (P<0.01), white willow (P<0.01) and red 
rooibos extracts (P<0.05). However, significant decreases were 
observed in 1,000 µg/ml hemp, cayenne pepper and bitter 
orange peel extracts (P<0.01; Fig. 2B).
To calculate the ic50 values of the three herb extracts, 
the dose-dependent inhibition of α-glucosidase activity was 
assessed (Fig. 3). The ic50 values were 801.3 (bearberry; 
95% CI, 751.9‑854.0; R2=0.9739; Fig. 3A), 744.6 (green tea; 
95% CI, 696.7‑795.1, R2=0.9767; Fig. 3B) and 724.0 µg/ml 
(coltsfoot; 95% CI, 641.9‑818.1; R2=0.9538; Fig. 3C).
Effects of bearberry, green tea and coltsfoot extracts on 
BGLs in rats. all rats were healthy before the experiments, 
and adverse events were not observed during the experiments. 
it was revealed that treatment with 2 g/kg maltose caused 
temporary hyperglycemia in the rats (maltose control 
group), as indicated by a significant increase in BGls at 
0.25 (P<0.01), 0.5 (P<0.01) and 1.0 h (P<0.05; Fig. 4a-d). 
BGls upon administration of 5 ml/kg bearberry extract were 
significantly lower compared with the levels in the maltose 
control group at 0.083 (P<0.05) and 0.5 h (P<0.01; Fig. 4a). 
Moreover, BGls after administration of 5 ml/kg green tea 
extract were significantly lower compared with the levels 
in the maltose control group at 0.5 h (P<0.01; Fig. 4B). in 
addition, BGls after administration of 5 ml/kg coltsfoot 
extract were significantly lower compared with the levels 
in the maltose control group at 0.25 (P<0.01) and 0.5 h 
(P<0.01; Fig. 4c). after administration of 5 ml/kg acarbose 
(24 mg/kg, positive control group) BGLs were significantly 
lower compared with the levels in the maltose control group 
at 0.25 (P<0.01), 0.5 (P<0.01) and 1.5 h (P<0.05; Fig. 4d). 
Furthermore, the auc of the acarbose group, compared 
with the maltose control group, was significantly decreased 
(P<0.05), but no significant differences were observed in 
each of the three herb extracts (Fig. 4e).
it was demonstrated that treatment with 2 g/kg glucose 
caused temporary hyperglycemia in the rats serving as the 
glucose control group, as indicated by a significant increase 
in BGls at 0.083 (P<0.05), 0.25 (P<0.01), 0.5 (P<0.01), 
1.0 (P<0.01) and 1.5 h (P<0.01; Fig. 5a-d). BGls after the 
administration of 5 ml/kg bearberry (Fig. 5a) and green tea 
extracts (Fig. 5B) were not significantly different compared 
with the levels of each time-point in the glucose control group. 
Moreover, BGls upon administration of 5 ml/kg coltsfoot 
extract were significantly lower compared with the levels of 
each time-point in the glucose control group at 0.25 (P<0.05) 
and 0.5 h (P<0.05; Fig. 5c). it was indicated that the aucs in 
Figure 1. diagram representing the timeline of treatment with hot-water extracts from herbs, maltose and glucose in rats.
Figure 2. inhibitory effect of herb extracts on α-glucosidase activity. 
dose-dependent inhibitory activity of (a) acarbose and (B) 1,000 µg/ml 
various herb extracts on α-glucosidase activity. data are presented as the 
mean ± Sd of three separate experiments. data were analyzed using an ordinary 
one-way anoVa followed by dunnett's test for multiple comparisons. 
†P<0.05 and §P<0.01 vs. the control.
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each of the three herb extracts were not significantly different 
compared with those in the glucose control group (Fig. 5d).
Discussion
in the present study, it was demonstrated that acarbose, an 
α‑glucosidase inhibitor, significantly inhibited α-glucosidase 
activity in vitro, indicating that acarbose can be used as a 
positive control in the measurement of this activity in vitro. in 
Figure 4. effects of bearberry, green tea and coltsfoot extracts on BGls. Blood 
glucose kinetics in maltose-treated rats after administration of (a) bearberry, 
(B) green tea, (c) coltsfoot and (d) acarbose extracts. (e) comparison of the 
AUCs. Data are presented as (A‑D) the mean ± SEM or (E) the mean ± 95% 
CI (n=6, respectively). Data were analyzed using (A‑D) a repeated‑measures 
two-way anoVa and (e) a repeated-measures one-way anoVa followed 
by Bonferroni's multiple comparison test. ¶P<0.05 and ‡P<0.01 vs. the BGl at 
time 0 in the maltose control group. †P<0.05 and §P<0.01 vs. the BGl at each 
time-point in the maltose control group. BGl, blood glucose level; auc, area 
under the curve.
Figure 3. inhibitory effect of herb extracts on α-glucosidase activity. 
dose-dependent inhibitory activity of (a) bearberry, (B) green tea and 
(c) coltsfoot extracts on α-glucosidase activity. data are presented as the 
mean ± Sd of three separate experiments.
KiKucHi et al:  In vitro and in vivo inHiBiTorY eFFecTS oF HerB eXTracTS on α-GlucoSidaSe acTiViTY3530
total, 6/26 herb extracts, olive, white willow, rooibos, bearberry, 
green tea and coltsfoot, significantly inhibited α-glucosidase 
activity in vitro. However, 3/26 herb extracts, hemp, cayenne 
pepper and bitter orange peel, induced significant α-glucosidase 
activation. although the mechanisms underlying the effects of 
these herbs are unknown, it was speculated that the inherent 
values of the herb extracts in the measurement of absorbance 
had an effect on the measurement of α-glucosidase activity.
olive leaf (Olea europea) is widely recognized as a natural 
resource with potential beneficial effects (15). Previous studies 
have reported that 80% aqueous ethanol extract of olive signif-
icantly inhibited BGls in starch-intubated into fasting healthy 
or streptozotocin (STZ)-injected diabetic Sprague-dawley 
rats, and treatment with olive extract was associated with a 
beneficial hypoglycemic effect in patients with diabetes (16). 
In addition, hot water and 98% ethanol extract was revealed 
to inhibit α-amylase activity, and olive powder and its phyto-
chemicals reduced BGls in GK/Jcl rats (known as type 2 
diabetic rats) orally treated with starch (17). Furthermore, 
hydroxytyrosol and oleuropein, phytochemicals in olive 
extracts were revealed to significantly inhibit α-glucosidase 
activity (18). Thus, both these previous results and those of 
the present study indicate that olive extract may induce a 
decrease in BGls via an α-glucosidase inhibitory effect.
Tea produced from rooibos (Aspalathus lineari) leaf is 
generally known as ‘rooibos tea’ or ‘rooibos tisane’ (19). 
Moreover, rooibos is classified as red or green depending 
on the presence or absence of fermentation treatment (19). 
Pharmacologically, rooibos is traditionally used in the treat-
ment of asthma, colic, eczema, headache, nausea and mild 
depression; it has also been used as an antihypertensive, 
immune stimulant, laxative, sedative and spasmolytic agent, as 
well as for the treatment of atherosclerosis and diabetes (19). 
a previous in vitro study reported that 65, 75 or 85˚C aqueous 
extracts from red (fermented) rooibos significantly inhibited 
α-glucosidase activity (20). However, an in vivo study by 
ulicná et al (21) revealed that hot aqueous extracts from 
fermented rooibos did not significantly affect plasma glucose, 
glycated hemoglobin and fructosamine levels in STZ-induced 
diabetic Wistar rats; similar results were also reported by 
ayeleso et al (22). Therefore, these studies and the present 
results indicated that the hot-water extract of red rooibos may 
not affect BGls via α-glucosidase inhibitory effects in vivo.
White willow, the white bark of Salix alba, is known to 
have an anti‑inflammatory effect resulting from the suppres-
sion of prostaglandin synthesis by salicin, the main component 
of white willow (23). However, there are few experiments on 
the hyperglycemic and/or α-glucosidase inhibitory effects 
of the white willow. The present results indicated that the 
white willow extract inhibited α-glucosidase activity in vitro; 
however, more detailed in vivo experiments are required in the 
future.
Bearberry (Arctostaphylos uva‑ursi) is one of the most 
commonly used antimicrobial botanicals for the treatment 
of urinary tract infections (24); however, only a few studies 
have been conducted to investigate its hyperglycemic and/or 
α-glucosidase inhibitory effects. Huerta et al (25) reported 
that 80˚C aqueous extracts of bearberry leaves inhibited 
α-amylase and α-glucosidase activity in vitro. Moreover, 
the present results demonstrated that bearberry extracts had 
≥50% inhibition of α-glucosidase activity (ic50=801.3 µg/ml). 
However, Swanston-Flatt et al (26) revealed that the use of 
standard powdered diets containing powdered bearberry 
ad libitum did not induce a reduction of the increasing BGls 
in STZ-injected adult male mice. in contrast, in the present 
Figure 5. effects of bearberry, green tea and coltsfoot extracts on BGls. Blood 
glucose kinetics in glucose-treated rats after administration of (a) bearberry, 
(B) green tea and (c) coltsfoot extracts. (d) comparison of the aucs. data 
are presented as (A‑C) the mean ± SEM or (D) the mean ± 95% CI (n=6, 
respectively). data were analyzed using (a-c) a repeated-measures two-way 
anoVa and (d) a repeated-measures one-way anoVa followed by 
Bonferroni's multiple comparison test. ¶P<0.05 and ‡P<0.01 vs. the BGl at 
time 0 in the glucose control group. †P<0.05 and §P<0.01 vs. the BGl at each 
time-point in the glucose control group. BGl, blood glucose level; auc, area 
under the curve.
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study, administration of bearberry extract reduced the 
increasing BGls until 0.5 h in maltose-treated rats, but not 
in glucose-treated rats. Furthermore, the administration of 
bearberry extract in rats did not reveal any effect on aucs, 
an indicator of glucose absorption. These differences may be 
because the present study used extracts different from those 
used by Swanston-Flatt et al (26). Therefore, the details of 
this result may become more evident in future studies using 
an animal model of diabetes. However, it can be speculated 
that bearberry can inhibit α-glucosidase activity, resulting in 
antihyperglycemic activity.
Camellia sinensis leaf is used to produce various types of 
teas, such as green tea, black tea and oolong tea; in particular, 
green tea is one of the most widely consumed beverages in 
the world (27). Previous studies on green tea, including those 
focusing on its antihyperglycemic, α-glucosidase inhibitory 
and antidiabetic activities, have been reported in vitro, in vivo 
and in clinical research (28-33). Furthermore, the present 
results demonstrated that each extract of green tea extract 
had ≥50% inhibition (IC50=744.6 µg/ml), and administration 
of green tea extract reduced the increasing BGls at 0.5 h in 
maltose-treated rats, but not in glucose-treated rats. However, 
the administration of green tea extract in rats had no effect 
on aucs. Moreover, similar results have been revealed by 
nishiumi et al (34); oGTT in mice when fed a control diet 
or high-fat diet with water, hot-water extracts of green tea or 
black tea demonstrated a in reduction the BGls. Furthermore, 
the effect on aucs was not found in control diet-fed mice, 
but was reduced in high-fat diet-fed mice (34). in addition, the 
intake of their extracts prevented the impairment of glucose 
transporter type 4-dependent glucose transport in muscle in 
high-fat diet-fed mice. Yang et al (35) revealed that weight 
reduction, alleviation of metabolic syndrome and risk reduction 
in diabetes were only observed in individuals who consume 
≥3‑4 cups of tea (600‑900 mg tea catechins) daily. Thus, based 
on all these results it was speculated that green tea may inhibit 
α-glucosidase activity, resulting in antihyperglycemic activity. 
Furthermore, the various effects of green tea may reduce the 
risk of diabetes.
numerous parts of coltsfoot (Tussilago farfara), including 
the flower buds, flowers, leaves and roots, have been tradi-
tionally used for the treatment of several conditions, such as 
colds, asthma, influenza, gastroenteritis diarrhea, metabolic 
stimulation and wounds in china, north africa, Siberia 
and europe (36). Moreover, uysal et al (37) reported that 
methanolic extracts from the leaves of coltsfoot exhibited 
significant α-glucosidase activity. in addition, Gao et al (38) 
and Sun et al (39) revealed that methanolic extracts from the 
flower buds of coltsfoot exhibited maltase inhibitory activity, 
with maltose as a substrate. However, the effects of hot-water 
extract obtained from the leaves of coltsfoot remain unknown. 
The present results demonstrated that coltsfoot extract had 
≥50% inhibition (IC50=724.0 µg/ml), and administration of 
coltsfoot extract reduced the increasing BGls until 0.5 h, not 
only in maltose-treated rats, but also in glucose-treated rats. 
However, the administration of coltsfoot extract in rats had 
no effect on aucs. These results indicated that the reducing 
effect of these extracts on increasing BGls results not only 
from the inhibition of α-glucosidase activity, but also from 
the absorption of dietary glucose. However, the effect of the 
absorption of dietary glucose requires further examination in 
future experiments, such as increasing BGls without intestinal 
absorption.
in conclusion, the present results revealed that the hot-water 
extracts from olive, white willow, red rooibos, bearberry, 
green tea and coltsfoot inhibited α-glucosidase activity 
in vitro. Moreover, bearberry, green tea and coltsfoot extracts 
suppressed BGl increase following maltose administration, 
due to their α-glucosidase inhibitory effects. Furthermore, 
it was demonstrated that coltsfoot extract exerted inhibitory 
effects on glucose absorption, as well as α-glucosidase 
activity. collectively, the present results may facilitate the 
understanding of the novel functionality in traditional herbs, 
which will aid in the prevention of disease onset and progression 
in hyperglycemia and type 2 diabetes, among other diseases. 
However, to assess the effective use of the present findings, 
the active substance(s) need to be identified and the improving 
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